Search Results

HiChem Cholesterol Reagent is intended for the quantitative determination of total cholesterol in serum and plasma for the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders.

The HiChem Cholesterol Reagent determines cholesterol through the enzymatic action of cholesterol esterase, cholesterol oxidase and peroxidase. The resulting increase in absorbance at one of interested estable concessed on concentration in the sample.

Here's an analysis of the acceptance criteria and the studies performed for the HiChem Cholesterol Reagent, based on the provided text.

1. Table of Acceptance Criteria and Reported Device Performance

The document describes two scenarios: the HiChem Cholesterol Reagent as a manual procedure and the HiChem Cholesterol Reagent used as a secondary reagent on Beckman® SYNCHRON CX® Systems. The acceptance criteria are largely implied by the reported performance figures, as specific pre-defined thresholds aren't explicitly stated as "acceptance criteria." However, the comparisons to the predicate device and specified ranges (e.g., linearity) serve as the de facto criteria.

Scenario 1: HiChem Cholesterol Reagent (Manual Procedure)

Ask a specific question about this device

HiChem Phosphorus Reagent is intended for the quantitative determination of inorganic phosphorus in serum, plasma and urine for the diagnosis and treatment of various disorders including parathyroid gland and kidney diseases, and vitamin D imbalance.

The HiChem Phosphorus Reagent determines phosphorus by its reaction with molybdate in an acidic solution to form a phosphomolybdate complex. The resulting increase in absorbance at 340 nm is proportional to the phosphorus concentration in the sample.

The HiChem Phosphorus Reagent is an adaptation of the method first described by Simonsen and is intended for use with manual spectrophotometers or clinical analyzers which can automate the required manipulations.

Here's a breakdown of the HiChem Phosphorus Reagent device's acceptance criteria and the study information as detailed in the provided document:

This document describes a diagnostic reagent, not an AI/ML powered device, therefore some of the requested information (like MRMC studies, number of experts for ground truth, adjudication methods) is not applicable. I will provide the information that is applicable based on the provided text.

1. Table of Acceptance Criteria and Reported Device Performance

Ask a specific question about this device

HiChem CK/NAC Reagent (product no. 70003) is intended for the quantitation of creatine kinase in serum and n homent of had not headly no room, seevated serum creatine kinase are diseases of the heart and skeletal muscle.

The HiChem CK/NAC Reagent determines creatine kinase by enzymation of adenosine diphosphate in the The rionoment of creatine the sphosphate. The rate of this reaction, and the activity of creatine kinase in the sociment is determined through the measurement of NADH which is formed through a series of linked enzymatic reactions.

The HiChern CK/NAC Reagent is intended to be used either as a manual procedure or on clinical analyzers which can THE HONEY ON WO Treagon IS The reagent is supplied as two liquit-stable components which are combined, ether adomails no roquined manyalance "The reason is to to series CK/NAC Reagent Buffer. The CK/NAC Bubstrate can also be used as a start reagent and combined with the Reagent Buffer following sample addition.

Here's an analysis of the provided text, focusing on the acceptance criteria and the study that proves the device meets them:

Device: HiChem CK/NAC Reagent (product no. 70003)
Intended Use: Quantitation of creatine kinase in serum. Elevated serum creatine kinase levels indicate diseases of the heart and skeletal muscle.

1. Table of Acceptance Criteria and Reported Device Performance

The document describes several performance characteristics for both manual and automated (Hitachi 704) procedures. The acceptance criteria are implicitly derived from the reported performance, as the document states these demonstrate the effectiveness of the reagent. For linearity and precision, the reported values often serve as the acceptance criteria themselves within the context of demonstrating "effectiveness." For comparison studies and stability, the acceptance criteria are explicitly stated as biases/shifts being below certain thresholds or strong correlation coefficients.

Study that Proves the Device Meets the Acceptance Criteria:

The document itself constitutes the summary of the studies performed to demonstrate safety and effectiveness, and ultimately, substantial equivalence to predicate devices. It describes a series of experiments and analyses for both manual and automated use of the HiChem CK/NAC Reagent.

2. Sample Sizes Used for the Test Set and Data Provenance

• Linearity (Manual): "linearity standards" (number not specified explicitly, but implies multiple points across the range).

• Precision (Manual): 30 replicates per serum control level (3 levels tested).

• Method Comparison (Manual): 90 mixed serum and plasma specimens.

• Chemical Additives (Manual): "spiked and unspiked serum pools" (number of pools/samples not specified, but implies comparative testing).

• Reagent Stability (Manual): "serum controls" (number of controls/data points not specified explicitly, but ranges from 50 to 1200 U/L CK).

• Linearity (Automated): "eleven linearity standards."

• Precision (Automated): 60 replicates per serum control level (3 levels tested).

• Method Comparison (Automated): 126 mixed serum and plasma specimens.

• Calibration Stability (Automated): "serum controls" spanning approximately 50 to 1,200 U/L CK (number of controls/data points not specified explicitly).

• On-board Stability (Automated): "the same serum controls" as for calibration stability (number of controls/data points not specified explicitly).

Data Provenance: Not explicitly stated (e.g., country of origin, retrospective or prospective). Given the nature of laboratory reagent testing for product submission, it is typically understood that these are prospective studies conducted in a controlled lab environment.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

This type of study does not involve "experts" establishing ground truth in the traditional sense of medical image interpretation (e.g., radiologists). Instead, the "ground truth" for the test set is established by:

• Reference materials: Known concentration "linearity standards" for linearity testing, "commercially available control sera" with known target values for precision testing.
• Predicate devices: The legally marketed Sigma Diagnostics Creatine Kinase (CK) Reagent and BMD CK/NAC Reagent serve as the reference standard (the "ground truth" or comparative standard) for method comparison studies.

Therefore, the concept of "number of experts" and their "qualifications" is not applicable here.

4. Adjudication Method for the Test Set

Not applicable. This is not a study requiring adjudication of interpretations (e.g., by multiple readers). The results are quantitative measurements compared against known values or established predicate methods.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done

No, an MRMC comparative effectiveness study was not done. This type of study is relevant for diagnostic devices that involve human interpretation of images or other subjective data, which is not the case for a quantitative chemical reagent.

6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done

This is essentially a standalone (algorithm/reagent only) performance study. The reagent itself, combined with either manual pipetting and spectrophotometry or an automated analyzer, generates the results. There isn't a "human-in-the-loop" component in the interpretation of the result from the device, only in the operation of the manual procedure. The automated procedure is even less human-in-the-loop for the measurement process.

7. The Type of Ground Truth Used

The ground truth used several forms:

• Reference Standards/Materials: For linearity, commercially prepared "linearity standards" with known, accurate creatine kinase concentrations are used. For precision, "commercially available control sera" with established target values are used.
• Predicate Device Measurements: For method comparison, the measurements obtained from legally marketed predicate devices (BMD CK/NAC Reagent and Sigma Diagnostics Creatine Kinase (CK) Reagent) on the same patient specimens serve as the comparative ground truth.

8. The Sample Size for the Training Set

Not applicable. This is a chemical reagent, not a machine learning algorithm that requires a "training set." The performance characteristics are derived from direct experimental measurements. The phrase "training set" is generally used in the context of AI/ML model development.

9. How the Ground Truth for the Training Set was Established

Not applicable, as there is no training set for this type of device.

Ask a specific question about this device

HiChem BUN/Urea Reagent (product no. 70006) is for the quantitative determination of urea nitrogen in serum. plasma and urine. Plasma urea levels are affected by a wide variety of factors including diet, increased protein catabolism and mild dehydration as well as many renal diseases. The major value of plasma urea measurement is in distinguishing between renal and non-renal related causes.

The HiChem BUN/Urea Reagent determines urea nitrogen through enzymatic hydrolysis by urease. The rate of this reaction, and the quantity of urea nitrogen in the specimen is monitored through the measurement of the resulting ammonia which oxidizes NADH to NAD in the presence of ox-keto-glutarate and glutamate dehydrogenase. The reagent is supplied as two liquid-stable reagent components which are intended to be combined, either before or during use, in the approximate ratio of 1 part BUN/Urea Enzyme Reagent and 5 parts BUN/Urea Buffer. The BUN/Urea Enzyme Reagent can also be used as a start reagent and combined with the reagent buffer after sample addition.

This document describes the performance of the HiChem BUN/Urea Reagent and compares it to existing reagents, rather than an AI-powered device. Therefore, many of the requested elements for an AI device study (e.g., sample size for AI test set, number of experts for ground truth, adjudication method, MRMC study, standalone performance, training set details) are not applicable.

However, I can extract the acceptance criteria and reported performance based on the provided text for the HiChem BUN/Urea Reagent.

1. Table of Acceptance Criteria and Reported Device Performance

The document doesn't explicitly state "acceptance criteria" with numerical thresholds for all evaluated aspects. Instead, it presents performance metrics and makes claims about substantial equivalence to predicate devices, linearity, and stability. I will infer acceptance criteria where possible from the claims made (e.g., linearity to at least 150 mgN/dL, shifts less than specified values for stability). For comparative studies, the acceptance is implied if the regression statistics (r², Sy.x) demonstrate strong agreement with the predicate device.

Manual Procedure:

Ask a specific question about this device